Biggest changeComparing fiscal 2022 and fiscal 2021, our results included the following: • an increase in net sales from $5.81 billion to $6.04 billion, representing period-over-period growth of 3.9%; • comparable sales growth of 4.5%; • net income attributable to Class A and B-1 common stockholders of $90.8 million, compared to net income attributable to Class A and B-1 common stockholders of $164.4 million in the prior year; and • Net cash flows provided by operating activities decreased from $358.2 million in fiscal 2021 to $346.0 million in fiscal 2022. 49 Results of Operations The following tables summarize our results of operations and the percent of net sales of line items included in our consolidated statements of operations (dollars in thousands): Fiscal years ended January 28, 2023 January 29, 2022 January 30, 2021 (52 weeks) (52 weeks) (52 weeks) Net sales $ 6,035,967 $ 5,807,149 $ 4,920,202 Cost of sales 3,608,860 3,380,539 2,813,464 Gross profit 2,427,107 2,426,610 2,106,738 Selling, general and administrative expenses 2,201,548 2,160,539 1,912,314 Operating income 225,559 266,071 194,424 Interest income (1,032 ) (62 ) (653 ) Interest expense 101,643 77,397 219,083 Loss on extinguishment and modification of debt — 20,838 17,549 Other non-operating loss (income) 12,667 (34,497 ) — Income (loss) before income taxes and income from equity method investees 112,281 202,395 (41,555 ) Income tax expense (benefit) 35,347 53,473 (3,337 ) Income from equity method investees (12,976 ) (10,883 ) (6,482 ) Net income (loss) 89,910 159,805 (31,736 ) Net loss attributable to noncontrolling interest (891 ) (4,612 ) (5,253 ) Net income (loss) attributable to Class A and B-1 common stockholders $ 90,801 $ 164,417 $ (26,483 ) Fiscal years ended January 28, 2023 January 29, 2022 January 30, 2021 (52 weeks) (52 weeks) (52 weeks) Net sales 100.0 % 100.0 % 100.0 % Cost of sales 59.8 58.2 57.2 Gross profit 40.2 41.8 42.8 Selling, general and administrative expenses 36.5 37.2 38.9 Operating income 3.7 4.6 3.9 Interest income (0.0 ) (0.0 ) (0.0 ) Interest expense 1.6 1.3 4.4 Loss on extinguishment and modification of debt — 0.4 0.3 Other non-operating loss (income) 0.2 (0.6 ) — Income (loss) before income taxes and income from equity method investees 1.9 3.5 (0.8 ) Income tax expense (benefit) 0.6 0.9 (0.1 ) Income from equity method investees (0.2 ) (0.2 ) (0.1 ) Net income (loss) 1.5 2.8 (0.6 ) Net loss attributable to noncontrolling interest 0.0 0.0 (0.1 ) Net income (loss) attributable to Class A and B-1 common stockholders 1.5 % 2.8 % (0.5 )% Fiscal years ended January 28, 2023 January 29, 2022 January 30, 2021 (52 weeks) (52 weeks) (52 weeks) Operational Data: Comparable sales increase 4.5 % 18.9 % 11.4 % Total pet care centers (U.S. and Puerto Rico) at end of period 1,430 1,433 1,454 Total veterinarian practices at end of period 247 197 125 50 Fiscal 2022 (52 weeks) Compared with Fiscal 2021 (52 weeks) Net Sales and Comparable Sales Fiscal years ended (dollars in thousands) January 28, 2023 January 29, 2022 $ Change % Change Consumables $ 2,859,602 $ 2,533,755 $ 325,847 12.9 % Supplies and companion animals 2,370,913 2,603,104 (232,191 ) (8.9 %) Services and other 805,452 670,290 135,162 20.2 % Net sales $ 6,035,967 $ 5,807,149 $ 228,818 3.9 % Net sales increased $228.8 million, or 3.9%, to $6.04 billion in fiscal 2022 compared to net sales of $5.81 billion in fiscal 2021, driven by a 4.5% increase in our comparable sales.
Biggest changeExecutive Summary Comparing fiscal 2023 and fiscal 2022, our results included the following: • an increase in net sales from $6.04 billion to $6.26 billion, representing period-over-period growth of 3.6%; • comparable sales growth of 1.8%; • net loss attributable to Class A and B-1 common stockholders of $1,280.2 million impacted by goodwill impairment, compared to net income attributable to Class A and B-1 common stockholders of $90.8 million in the prior year; and • A decrease in Adjusted EBITDA from $530.8 million to $401.1 million. 51 Results of Operations The following tables summarize our results of operations and the percent of net sales of line items included in our consolidated statements of operations (dollars in thousands): Fiscal years ended February 3, 2024 January 28, 2023 January 29, 2022 (53 weeks) (52 weeks) (52 weeks) Net sales: Products $ 5,273,710 $ 5,230,515 $ 5,136,859 Services and other 981,574 805,452 670,290 Total net sales 6,255,284 6,035,967 5,807,149 Cost of sales: Products 3,269,628 3,035,249 2,875,313 Services and other 631,821 573,611 505,226 Total cost of sales 3,901,449 3,608,860 3,380,539 Gross profit 2,353,835 2,427,107 2,426,610 Selling, general and administrative expenses 2,311,625 2,201,548 2,160,539 Goodwill impairment 1,222,524 — — Operating (loss) income (1,180,314 ) 225,559 266,071 Interest income (3,405 ) (1,032 ) (62 ) Interest expense 150,909 101,643 77,397 Loss on extinguishment and modification of debt 920 — 20,838 Other non-operating (income) loss (4,727 ) 12,667 (34,497 ) (Loss) income before income taxes and income from equity method investees (1,324,011 ) 112,281 202,395 Income tax (benefit) expense (27,613 ) 35,347 53,473 Income from equity method investees (16,188 ) (12,976 ) (10,883 ) Net (loss) income (1,280,210 ) 89,910 159,805 Net loss attributable to noncontrolling interest — (891 ) (4,612 ) Net (loss) income attributable to Class A and B-1 common stockholders $ (1,280,210 ) $ 90,801 $ 164,417 52 Fiscal years ended February 3, 2024 January 28, 2023 January 29, 2022 (53 weeks) (52 weeks) (52 weeks) Net sales: Products 84.3 % 86.7 % 88.5 % Services and other 15.7 13.3 11.5 Total net sales 100.0 100.0 100.0 Cost of sales: Products 52.3 50.3 49.5 Services and other 10.1 9.5 8.7 Total cost of sales 62.4 59.8 58.2 Gross profit 37.6 40.2 41.8 Selling, general and administrative expenses 37.0 36.5 37.2 Goodwill impairment 19.5 — — Operating (loss) income (18.9 ) 3.7 4.6 Interest income (0.1 ) (0.0 ) (0.0 ) Interest expense 2.5 1.6 1.3 Loss on extinguishment and modification of debt 0.0 — 0.4 Other non-operating (income) loss (0.1 ) 0.2 (0.6 ) (Loss) income before income taxes and income from equity method investees (21.2 ) 1.9 3.5 Income tax (benefit) expense (0.4 ) 0.6 0.9 Income from equity method investees (0.3 ) (0.2 ) (0.2 ) Net (loss) income (20.5 ) 1.5 2.8 Net loss attributable to noncontrolling interest — 0.0 0.0 Net (loss) income attributable to Class A and B-1 common stockholders (20.5 )% 1.5 % 2.8 % Fiscal years ended February 3, 2024 January 28, 2023 January 29, 2022 (53 weeks) (52 weeks) (52 weeks) Operational Data: Comparable sales increase 1.8 % 4.5 % 18.9 % Total pet care centers (U.S. and Puerto Rico) at end of period 1,423 1,430 1,433 Total veterinarian practices at end of period 288 247 197 Fiscal 2023 (53 weeks) Compared with Fiscal 2022 (52 weeks) Net Sales and Comparable Sales Fiscal years ended (dollars in thousands) February 3, 2024 January 28, 2023 $ Change % Change Consumables $ 3,063,845 $ 2,859,602 $ 204,243 7.1 % Supplies and companion animals 2,209,865 2,370,913 (161,048 ) (6.8 %) Services and other 981,574 805,452 176,122 21.9 % Net sales $ 6,255,284 $ 6,035,967 $ 219,317 3.6 % Net sales increased $219.3 million, or 3.6%, to $6.26 billion in fiscal 2023 compared to net sales of $6.04 billion in fiscal 2022, driven by a 1.8% increase in our comparable sales and an increase of $116.6 million as a result of the 53rd week in fiscal 2023.
Adjusted EBITDA is not a substitute for net income (loss), the most comparable GAAP measure, and is subject to a number of limitations as a financial measure, so it should be used in conjunction with GAAP financial measures and not in isolation. There can be no assurances that we will not modify the presentation of Adjusted EBITDA in the future.
Adjusted EBITDA is not a substitute for net (loss) income, the most comparable GAAP measure, and is subject to a number of limitations as a financial measure, so it should be used in conjunction with GAAP financial measures and not in isolation. There can be no assurances that we will not modify the presentation of Adjusted EBITDA in the future.
Refer also to further discussion on our debt refinancing transaction in “Sources of Liquidity” below. Purchase obligations and commitments consist of open purchase orders, non-cancellable commitments for information technology, marketing and other products and services used in the normal course of business as well as 55 our commitment for naming rights to the baseball stadium.
Refer also to further discussion on our debt refinancing transaction in “Sources of Liquidity” below. Purchase obligations and commitments consist of open purchase orders, non-cancellable commitments for information technology, marketing and other products and services used in the normal course of business as well as our commitment for naming rights to the baseball stadium.
We perform our annual impairment test during the fourth quarter of each year or whenever events or changes in circumstances indicate the carrying value may not be recoverable. Management has the option to first perform a quantitative assessment of its trade name asset to determine whether it is necessary to perform a quantitative impairment test.
We perform our annual impairment test during the fourth quarter of each year or whenever events or changes in circumstances indicate the carrying value may not be recoverable. Management has the option to first perform a qualitative assessment of its trade name asset to determine whether it is necessary to perform a quantitative impairment test.
Net cash provided by operating activities is impacted by our net income (loss) adjusted for certain non-cash items, including: depreciation, amortization, impairments and write-offs; amortization of debt discounts and issuance costs; deferred income taxes; equity-based compensation; impairments of intangible assets; other non-operating income; and the effect of changes in operating assets and liabilities.
Net cash provided by operating activities is impacted by our net (loss) income adjusted for certain non-cash items, including: depreciation, amortization, impairments and write-offs; amortization of debt discounts and issuance costs; deferred income taxes; equity-based compensation; impairments of goodwill and intangible assets; other non-operating (income) loss; and the effect of changes in operating assets and liabilities.
In December 2022, we amended our first lien term loan facility and our revolving credit facility to replace the LIBOR-based rate 48 with a SOFR-based rate as the interest rate benchmark. Please read the discussion under “Liquidity and Capital Resources—Sources of Liquidity” for further information.
In December 2022, we amended our first lien term loan facility and our revolving credit facility to replace the LIBOR-based rate with a SOFR-based rate as the interest rate benchmark. Please read the discussion under “Liquidity and Capital Resources—Sources of Liquidity” for further information.
Management believes that Free Cash Flow, which measures our ability to generate additional cash from our business operations, is an important financial measure for use in evaluating the Company’s financial performance. Although other companies report their free cash flow, numerous methods exist for calculating a company’s free cash flow.
Management believes that Free Cash Flow, which measures our ability to generate additional cash from our business operations, is an important financial measure for use in evaluating the Company’s financial performance. 56 Although other companies report their free cash flow, numerous methods exist for calculating a company’s free cash flow.
If the carrying value of net assets assigned to the reporting unit exceeds the fair value of the 59 reporting unit, then we would record an impairment loss equal to the difference. In cases where a quantitative test is performed, the fair value of our reporting unit is estimated using the assistance of a third-party valuation firm.
If the carrying value of net assets assigned to the reporting unit exceeds the fair value of the reporting unit, then we would record an impairment loss equal to the difference. In cases where a quantitative test is performed, the fair value of our reporting unit is estimated using the assistance of a third-party valuation firm.
How We Assess the Performance of Our Business In assessing our performance, we consider a variety of performance and financial measures including the following: Comparable Sales Comparable sales is an important measure throughout the retail industry and includes both retail and digital sales of products and services.
How We Assess the Performance of Our Business In assessing our performance, we consider a variety of performance and financial measures including the following: 47 Comparable Sales Comparable sales is an important measure throughout the retail industry and includes both retail and digital sales of products and services.
Loss on Extinguishment and Modification of Debt In fiscal 2022, the Company did not recognize any losses on extinguishment or modification of debt. In fiscal 2021, the Company recognized $20.8 million of losses on the March 2021 refinancing of the Amended Term Loan Facility and Amended Revolving Credit Facility.
In fiscal 2022, the Company did not recognize any losses on extinguishment or modification of debt. In fiscal 2021, the Company recognized $20.8 million of losses on the March 2021 refinancing of the Amended Term Loan Facility and Amended Revolving Credit Facility.
Net sales are driven by comparable sales, new pet center locations, and expanded offerings. 47 Cost of Sales and Gross Profit Gross profit is equal to our net sales minus our cost of sales. Gross profit rate measures gross profit as a percentage of net sales.
Net sales are driven by comparable sales, new pet center locations, and expanded offerings. Cost of Sales and Gross Profit Gross profit is equal to our net sales minus our cost of sales. Gross profit rate measures gross profit as a percentage of net sales.
(6) We define net margin as net income (loss) attributable to Class A and B-1 common stockholders divided by net sales and Adjusted EBITDA margin as Adjusted EBITDA divided by net sales. Free Cash Flow Free Cash Flow is a non-GAAP financial measure that is calculated as net cash provided by operating activities less cash paid for fixed assets.
(4) We define net margin as net (loss) income attributable to Class A and B-1 common stockholders divided by net sales and Adjusted EBITDA margin as Adjusted EBITDA divided by net sales. Free Cash Flow Free Cash Flow is a non-GAAP financial measure that is calculated as net cash provided by operating activities less cash paid for fixed assets.
Net Loss Attributable to Noncontrolling Interest The noncontrolling interest represents 50% of the net loss of our veterinary joint venture, which is a variable interest entity for which we were deemed to be the primary beneficiary beginning in fiscal 2019 due to revisions made in the joint operating agreement.
Net Loss Attributable to Noncontrolling Interest The noncontrolling interest represents 50% of the net loss of our veterinary joint venture, which was a variable interest entity for which we were deemed to be the primary beneficiary beginning in fiscal 2019 due to revisions made in the joint operating agreement.
Our cost of sales includes the following types of expenses: • direct costs (net of vendor rebates, allowances, and discounts for products sold) including inbound freight charges; • shipping and handling costs associated with sales to customers; • freight costs associated with moving merchandise inventories; • inventory shrinkage costs and write-downs; • payroll costs of pet groomers, trainers, veterinarians, and other direct costs of services; and • costs associated with operating our distribution centers including payroll, occupancy costs and depreciation.
Our cost of sales includes the following types of expenses: • direct costs (net of vendor rebates, allowances, and discounts for products sold) including inbound freight charges; • shipping and handling costs associated with sales to customers; • freight costs associated with moving merchandise inventories; • inventory shrinkage costs and write-downs; • payroll and benefit costs of pet groomers, trainers, veterinarians, and other direct costs of services; and 49 • costs associated with operating our distribution centers including payroll and benefits, occupancy costs, and depreciation.
While these investments provided a key foundation and drive increased sales, ongoing performance of the business will depend on our ability to leverage our existing distribution network and pet care center locations for product delivery and fulfillment, including BOPUS, curbside pick-up, and same day delivery, and build upon and enhance these efforts.
While these investments provide a key foundation and help drive increased sales, ongoing performance of the business will depend on our ability to leverage our existing distribution network and pet care center locations for product delivery and fulfillment, including BOPUS, curbside pick-up, and same day delivery, and build upon and enhance these efforts.
In the financial statements, this joint venture is accounted for as an equity method investment and reported net of depreciation and income taxes. Because such a presentation would not reflect the adjustments made in the calculation of Adjusted EBITDA, we include the 50 percent interest in the company’s Mexico joint venture on an Adjusted EBITDA basis to ensure consistency.
In the financial statements, this joint venture is accounted for as an equity method investment and reported net of depreciation and income taxes. Because such a presentation would not reflect the adjustments made in our calculation of Adjusted EBITDA, we include our 50% interest in our Mexico joint venture on an Adjusted EBITDA basis to ensure consistency.
For more information regarding this activity, refer to Note 10, “Fair Value Measurements,” to the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K.
For more information refer to Note 9, “Fair Value Measurements,” to the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K.
The base rate is the greater of the bank prime rate, federal funds effective rate plus 0.5% or Adjusted Term SOFR plus 1.0%. The applicable rate is 2.25% per annum for a base rate loan or 3.25% per annum for an Adjusted Term SOFR loan. Principal and interest payments commenced on June 30, 2021. Principal payments are $4.25 million quarterly.
The base rate is the greater of the bank prime rate, federal funds effective rate plus 0.5% or Adjusted Term SOFR plus 1.0%. The applicable rate is 2.25% per annum for a base rate loan or 3.25% per annum for an Adjusted Term SOFR loan. Principal and interest payments commenced on June 30, 2021.
Our multicategory, go-to-market strategy integrates our strong digital assets with our nationwide physical footprint to meet the needs of pet parents who are looking for a single source for all their pet’s needs.
Our multicategory strategy integrates our digital assets with our nationwide physical footprint to meet the needs of pet parents who are looking for a single source for all their pet’s needs.
Prior Year Discussion of Results and Comparisons For information on fiscal 2021 results and similar comparisons, please read “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our previous Annual Report on Form 10-K filed with the SEC on March 24, 2022.
Prior Year Discussion of Results and Comparisons For information on fiscal 2022 results and similar comparisons, please read “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our previous Annual Report on Form 10-K filed with the SEC on March 28, 2023.
The increase in capital expenditures between the periods was primarily due to the build-out of our veterinary hospitals, innovation, capital expenditures for our new distribution centers and enhanced supply chain capacity in response to our sales growth.
The increase in capital expenditures between fiscal 2022 and fiscal 2021 was primarily due to the build-out of our veterinary hospitals, innovation, capital expenditures for our new distribution centers and enhanced supply chain capacity in response to our sales growth.
Refer to Note 5, “ Leases ,” and Note 7, “ Senior Secured Credit Facilities ,” in the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K for amounts outstanding as of January 28, 2023 related to operating leases and debt, respectively.
Refer to Note 5, “ Leases ,” and Note 7, “ Senior Secured Credit Facilities ,” in the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K for amounts outstanding as of February 3, 2024 related to operating leases and debt, respectively.
We are unable to quantify the factors impacting gross profit rate described above due to the fact that such factors are based on input measures or qualitative information that do not lend themselves to quantification. Selling, General and Administrative Expenses SG&A expenses increased $41.0 million, or 1.9%, to $2.20 billion for fiscal 2022 compared to $2.16 billion for fiscal 2021.
We are unable to quantify the factors impacting gross profit rate described above due to the fact that such factors are based on input measures or qualitative information that do not lend themselves to quantification. Selling, General and Administrative Expenses SG&A expenses increased $110.1 million, or 5.0%, to $2.31 billion for fiscal 2023 compared to $2.20 billion for fiscal 2022.
These obligations impact our short-term and long-term liquidity and capital resource needs. Certain contractual obligations are reflected on the consolidated balance sheet as of January 28, 2023, while others are considered future obligations. Our contractual obligations primarily consist of operating leases and long-term debt and related interest payments.
These obligations impact our short-term and long-term liquidity and capital resource needs. Certain contractual obligations are reflected on the consolidated balance sheet as of February 3, 2024, while others are considered future obligations. Our contractual obligations primarily consist of operating leases and long-term debt and related interest payments.
However, if estimates of losses are inaccurate, we may be exposed to losses or gains that could be material. A 10% difference in our actual shrink reserve at January 28, 2023 would have affected pre-tax income by $3.5 million in fiscal 2022. 58 Vendor Allowances We receive various forms of consideration from our merchandise vendors (vendor allowances).
However, if estimates of losses are inaccurate, we may be exposed to losses or gains that could be material. A 10% difference in our actual shrink reserve at February 3, 2024 would have affected pre-tax loss by $3.5 million in fiscal 2023. Vendor Allowances We receive various forms of consideration from our merchandise vendors (vendor allowances).
In tandem with Petco Love (formerly the Petco Foundation), an independent nonprofit organization, we work with and support thousands of local animal welfare groups across the country and, through in-store adoption events, we have helped find homes for nearly 7 million animals.
In tandem with Petco Love, a life-changing independent nonprofit organization, we work with and support thousands of local animal welfare groups across the country and, through in-store adoption events, we have helped find homes for nearly 7 million animals.
Our business will be impacted by our ability to continue to understand and react to changing customer purchase trends Customer Acquisition, Retention, and Spend Our business is impacted by our ability to successfully attract new customers to any one of our channels, build their loyalty to encourage return visits, and expand their spend with Petco across multiple purchase channels (e.g., pet care centers, e-commerce, and services) and categories (e.g., pet food, supplies, and companion animal).
Customer Acquisition, Retention, and Spend Our business is impacted by our ability to successfully attract new customers to any one of our channels, build their loyalty to encourage return visits, and expand their spend with Petco across multiple purchase channels (e.g., pet care centers, e-commerce, and services) and categories (e.g., pet food, supplies, and companion animals).
The non-GAAP financial measures presented may differ from similarly-titled measures used by other companies. 52 Adjusted EBITDA We present Adjusted EBITDA, a non-GAAP financial measure, because we believe it enhances an investor’s understanding of our financial and operational performance by excluding certain material non-cash items, unusual or non-recurring items that we do not expect to continue in the future, and certain other adjustments we believe are or are not reflective of our ongoing operations and performance.
Adjusted EBITDA We present Adjusted EBITDA, a non-GAAP financial measure, because we believe it enhances an investor’s understanding of our financial and operational performance by excluding certain material non-cash items, unusual or non-recurring items that we do not expect to continue in the future, and certain other adjustments we believe are or are not reflective of our ongoing operations and performance.
Investing Activities Net cash used in investing activities was $320.3 million, $237.1 million, and $157.2 million for fiscal 2022, fiscal 2021, and fiscal 2020, respectively, and consisted primarily of capital expenditures supporting our growth and initiatives.
Investing Activities Net cash used in investing activities was $207.4 million, $320.3 million, and $237.1 million for fiscal 2023, fiscal 2022, and fiscal 2021, respectively, and consisted primarily of capital expenditures supporting our growth and initiatives.
Historically, adjustments to our vendor income deferral have not been material. A 10% difference in our vendor income deferred at January 28, 2023 would have affected pre-tax income by $3.1 million in fiscal 2022. We have not made any material changes in the accounting methodology we use to assess valuation allowances during the past three fiscal years.
Historically, adjustments to our vendor income deferral have not been material. A 10% difference in our vendor income deferred at February 3, 2024 would have affected pre-tax loss by $2.3 million in fiscal 2023. We have not made any material changes in the accounting methodology we use to assess vendor allowances during the past three fiscal years.
We are increasingly linking our offerings with membership programs such as Vital Care Premier and pet health insurance that create deeper engagement with our customers, and with our Vital Care Core loyalty program members specifically, which members accounted for over 85% of transactions in fiscal 2022.
We are increasingly linking our offerings with membership programs such as Vital Care Premier and pet health insurance in an effort to create deeper engagement with our customers, and with our Vital Care Core loyalty program members specifically, which members accounted for over 90% of transactions in fiscal 2023.
Other costs beginning in fiscal 2023 will include as incurred: restructuring costs and restructuring-related severance costs; legal reserves associated with significant, non-ordinary course legal or regulatory matters; and costs related to certain significant strategic transactions.
(3) Other costs include, as incurred: restructuring costs and restructuring-related severance costs; legal reserves associated with significant, non-ordinary course legal or regulatory matters; and costs related to certain significant strategic transactions.
The increase in services and other was due in part to the increase in new pets, growth in our membership offerings including Vital Care Premier and Vital Care Core, and growth in our grooming services and veterinary hospital business in which we now operate 247 veterinary hospitals – an increase of 50 over the prior year.
The increase in services and other was due to growth in our membership offerings including Vital Care Premier and Vital Care Core, and growth in our grooming services and veterinary business in which we now operate 288 veterinary hospitals – an increase of 41 over the prior year.
Net Income (Loss) Attributable to Class A and B-1 Common Stockholders Net income attributable to Class A and B-1 common stockholders was $90.8 million for fiscal 2022 compared with a net income attributable to Class A and B-1 common stockholders of $164.4 million for fiscal 2021.
Net Income (Loss) Attributable to Class A and B-1 Common Stockholders Net loss attributable to Class A and B-1 common stockholders was $(1,280.2) million for fiscal 2023 compared with a net income attributable to Class A and B-1 common stockholders of $90.8 million for fiscal 2022.
For more information regarding this indebtedness, refer to Note 7, “ Senior Secured Credit Facilities ,” in the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K.
All other key terms of the ABL Revolving Credit Facility remained unchanged. For more information regarding this indebtedness, refer to Note 7, “ Senior Secured Credit Facilities ,” in the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K.
Cash Flows The following table summarizes our consolidated cash flows: Fiscal years ended (dollars in thousands) January 28, 2023 January 29, 2022 January 30, 2021 (52 weeks) (52 weeks) (52 weeks) Total cash provided by (used in): Operating activities $ 346,003 $ 358,215 $ 268,615 Investing activities (320,324 ) (237,083 ) (157,185 ) Financing activities (33,842 ) (18,782 ) (146,608 ) Net (decrease) increase in cash, cash equivalents and restricted cash $ (8,163 ) $ 102,350 $ (35,178 ) Operating Activities Our primary source of operating cash is sales of products and services to customers, which are substantially all on a cash basis, and therefore provide us with a significant source of liquidity.
Cash Flows The following table summarizes our consolidated cash flows: Fiscal years ended (dollars in thousands) February 3, 2024 January 28, 2023 January 29, 2022 (52 weeks) (52 weeks) (52 weeks) Total cash provided by (used in): Operating activities $ 215,719 $ 346,003 $ 358,215 Investing activities (207,445 ) (320,324 ) (237,083 ) Financing activities (85,352 ) (33,842 ) (18,782 ) Net (decrease) increase in cash, cash equivalents and restricted cash $ (77,078 ) $ (8,163 ) $ 102,350 57 Operating Activities Our primary source of operating cash is sales of products and services to customers, which are substantially all on a cash basis, and therefore provide us with a significant source of liquidity.
Through our integrated ecosystem, we provide our over 25 million total active customers with a comprehensive offering of differentiated products and services to fulfill their pets’ health and wellness needs through our more than 1,500 pet care centers in the U.S., Mexico, and Puerto Rico, including a growing network of 247 in-store veterinary hospitals, our digital channel, and our flexible fulfillment options.
Through our omnichannel ecosystem, we provide our customers with a comprehensive offering of products and services to fulfill their pets’ health and wellness needs through our more than 1,500 pet care centers in the U.S., Mexico, and Puerto Rico, including a growing network of 288 full service veterinary hospitals, our digital channel, and our flexible fulfillment options.
These losses and gains relate to non-cash remeasurements of the fair value of our investment in Rover Group, Inc. which began after the consummation of its merger with a publicly traded special purpose acquisition company in fiscal 2021.
These gains and losses related to remeasurements of the fair value of the Company's investment in Rover Group, Inc., which began after the consummation of its merger with a publicly traded special purpose acquisition company in fiscal 2021. In fiscal 2023, the Company sold its interest in Rover Group, Inc.
As a percentage of net sales, SG&A expenses decreased from 37.2% in fiscal 2021 to 36.5% in fiscal 2022 reflecting operating leverage from net sales growth. The increase in SG&A expenses period-over-period was to support our growth as we continue to invest in people, infrastructure and marketing.
As a percentage of net sales, SG&A expenses increased from 36.5% in fiscal 2022 to 37.0% in fiscal 2023. The increase in SG&A expenses period-over-period was to support our growth as we continue to invest in infrastructure and our people.
The table below reflects the calculation of Free Cash Flow for the periods presented: Fiscal years ended January 28, 2023 January 29, 2022 January 30, 2021 (dollars in thousands) (52 weeks) (52 weeks) (52 weeks) Net cash provided by operating activities $ 346,003 $ 358,215 $ 268,615 Cash paid for fixed assets (278,020 ) (239,110 ) (159,560 ) Free Cash Flow $ 67,983 $ 119,105 $ 109,055 Liquidity and Capital Resources Overview Our primary sources of liquidity are funds generated by operating activities and available capacity for borrowings on our $500 million secured asset-based revolving credit facility maturing March 4, 2026 (the “ABL Revolving Credit Facility”).
The table below reflects the calculation of Free Cash Flow for the periods presented: Fiscal years ended February 3, 2024 January 28, 2023 January 29, 2022 (dollars in thousands) (53 weeks) (52 weeks) (52 weeks) Net cash provided by operating activities $ 215,719 $ 346,003 $ 358,215 Cash paid for fixed assets (225,598 ) (278,020 ) (239,110 ) Free Cash Flow $ (9,879 ) $ 67,983 $ 119,105 Liquidity and Capital Resources Overview Our primary sources of liquidity are funds generated by operating activities and available capacity for borrowings on our secured asset-based revolving credit facility (the “ABL Revolving Credit Facility”).
If management concludes, based on assessment of relevant events, facts, and circumstances, that it is more likely than not that a reporting unit’s fair value is greater than its carrying value, no further impairment testing is required.
If management concludes, based on assessment of relevant events, facts, and circumstances, that it is more likely than not that a reporting unit’s fair value is greater than its carrying value, no further impairment testing is required. 61 If management’s assessment of qualitative factors indicates that it is more likely than not that the fair value of a reporting unit is less than its carrying value, then a quantitative assessment is performed.
Such non-GAAP financial measures are not calculated in accordance with GAAP and should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the most comparable GAAP measures.
Such non-GAAP financial measures are not calculated in accordance with GAAP and should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the most comparable GAAP measures. The non-GAAP financial measures presented may differ from similarly-titled measures used by other companies.
Income Tax Expense (Benefit) Our effective tax rate was 28.0% for fiscal 2022, resulting in income tax expense of $35.3 million, compared to an effective tax rate of 24.5% and income tax expense of $53.5 million for fiscal 2021.
Income Tax (Benefit) Expense Our effective tax rate was 2.1% for fiscal 2023, resulting in income tax benefit of $27.6 million, compared to an effective tax rate of 28.0% and income tax expense of $35.3 million for fiscal 2022.
Please read the discussion of these assets under “Critical Accounting Policies and Estimates.” Interest Expense Our interest expense in fiscal 2020 and a portion of fiscal 2021 was primarily associated with a term loan facility, a revolving credit facility, the Floating Rate Senior Notes (as defined herein), the 3.00% Senior Notes (as defined herein), and interest rate caps.
Please read the discussion of these assets under “Critical Accounting Policies and Estimates.” Interest Expense Our interest expense in fiscal 2021 was primarily associated with a term loan facility, and a revolving credit facility.
For more information regarding these activities, refer to Note 7, “ Senior Secured Credit Facilities ,” and Note 9, “ Senior Notes ,” in the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K.
For more information regarding these activities, refer to Note 7, “ Senior Secured Credit Facilities ,” in the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K. 54 Other Non-Operating (Income) Loss Other non-operating income was $4.7 million and other non-operating loss was $12.7 million for fiscal 2023 and fiscal 2022, respectively.
Significant assumptions inherent in the valuation methodologies employed by the third party valuation firm could include, but are not limited to, prospective financial information, growth rates, discount rates and comparable multiples from publicly traded companies in similar industries. An impairment charge is recorded for the amount by which the carrying amount of the trade name exceeds its fair value.
Significant assumptions used in the determination of fair value of the trade name generally include prospective financial information, growth rates, discount rates and comparable multiples from publicly traded companies in similar industries. An impairment charge is recorded for the amount by which the carrying amount of the trade name exceeds its fair value.
This is the primary focus of all our customer engagement efforts from digital, to performance marketing campaigns, to new product introductions, and to Petco partner cross- and up-selling activities in pet care centers. The ability to convert more of our customers to loyal, multi-channel shoppers will positively affect business performance.
This is the primary focus of our customer engagement efforts from digital, to performance marketing campaigns, to new product introductions, and to Petco partner cross- and up-selling activities in pet care centers.
The decrease in supplies and companion animals sales is due in part to a strong stimulus driven fiscal 2021 and a decrease in spending on certain non-essential items.
The decrease in supplies and companion animal sales is due to a decrease in spending on certain non-essential items.
A 10% difference in our actual valuation reserve at January 28, 2023 would have an insignificant effect on pre-tax income in fiscal 2022. Additionally, we do not believe there is a reasonable likelihood that there will be a material change in future estimates or assumptions we use to calculate our shrink reserve.
A 10% difference in our actual valuation reserve at February 3, 2024 would have affected pre-tax loss by $1.6 million in fiscal 2023. Additionally, we do not believe there is a reasonable likelihood that there will be a material change in future estimates or assumptions we use to calculate our shrink 60 reserve.
Our e-commerce site and personalized mobile app serve as hubs for pet parents to manage their pets’ health, wellness, and merchandise needs, while enabling them to shop wherever, whenever, and however they want.
Our e-commerce site and mobile app serve as hubs for pet parents to manage their pets’ health, wellness, and merchandise needs, while enabling them to shop wherever, whenever, and however they want. The full value of our ecosystem can be realized through our Vital Care Premier membership program.
In March 2023, the Company repaid $35.0 million on the First Lien Term Loan using existing cash on hand. The repayment was applied to remaining principal payments in order of scheduled payment date.
Principal payments are typically $4.25 million quarterly. In March 2023, May 2023 and August 2023, the Company repaid $35.0 million, $25.0 million and $15.0 million in principal, respectively, of the First Lien Term Loan using existing cash on hand. The repayments were applied to remaining principal payments in order of scheduled payment date.
In fiscal 2022, pet care center merchandise delivered growth of 1.4% with higher retail traffic and strong growth. Strength in consumables continues to offset the impact of discretionary purchasing in supplies and companion animals. Our e-commerce and digital sales increased 10.5% from fiscal 2021 to fiscal 2022, driven by strength in our digital pharmacy and repeat customers.
In fiscal 2023, pet care center merchandise revenue increased 1.0%, which partially offset the impact of lower discretionary purchasing in supplies and companion animals. Our e-commerce and digital sales increased 8.5% from fiscal 2022 to fiscal 2023, driven by strength in our digital pharmacy and repeat customers.
A long-lived asset is not recoverable if its carrying amount exceeds the sum of the undiscounted cash flows expected to result from its use and eventual disposition.
Long-lived assets are reviewed for impairment at the lowest level of identifiable cash flows, and are not recoverable if the carrying amount exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition.
Derivative Instruments 57 In November 2022, the Company entered into a series of interest rate cap agreements to limit the maximum interest on a portion of the Company’s variable-rate debt and decrease its exposure to interest rate variability when three-month SOFR as published by CME Group exceeds 4.5%.
Derivative Instruments In November 2022, the Company entered into a series of interest rate cap agreements to limit the maximum interest on a portion of the Company’s variable-rate debt and decrease its exposure to interest rate variability relating to three-month Term SOFR. The interest rate caps became effective December 30, 2022 and expire on December 31, 2024.
Recent Accounting Pronouncements Refer to Note 1, “ Summary of Significant Accounting Policies ,” in the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K for information regarding recently issued accounting pronouncements.
A 10% change in our self-insurance reserves at February 3, 2024 would have affected pre-tax loss by $8.9 million in fiscal 2023. 62 Recent Accounting Pronouncements Refer to Note 1, “ Summary of Significant Accounting Policies ,” in the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K for information regarding recently issued accounting pronouncements.
Income Tax Expense (Benefit) Income taxes consist of an estimate of federal and state income taxes based on enacted federal and state tax rates, as adjusted for allowable credits, deductions, and the valuation allowance against deferred tax assets, as applicable.
Income Tax Expense (Benefit) Income taxes consist of an estimate of federal and state income taxes based on enacted federal and state tax rates, as adjusted for allowable credits, deductions, and the valuation allowance against deferred tax assets, as applicable. 50 Income from Equity Method Investees Investments for which the Company exercises significant influence but does not have control are accounted for under the equity method.
These include third-party professional and legal fees and other integration-related costs that would not have otherwise been incurred as part of the Company’s operations.
These include third-party professional and legal fees and other integration-related costs that would not have otherwise been incurred as part of the Company’s operations. In fiscal 2022, approximately $8.2 million of these integration costs was recorded in cost of sales, and $7.1 million of these integration costs was recorded in selling, general and administrative expenses.
In addition to providing differentiated products and services, our over 26,000 knowledgeable, passionate partners in our pet care centers provide important high-quality advice to our customers. 45 Macroeconomic factors, including rising interest rates, inflationary pressures, supply chain constraints, global economic and geopolitical developments, and the prolonged COVID-19 pandemic have varying impacts on our results of operations, such as decreases in sales of discretionary items like supplies, that are difficult to isolate and quantify.
Macroeconomic factors, including rising interest rates, inflationary pressures, supply chain constraints, and global economic and geopolitical developments have had varying impacts on our results of operations, such as decreases in sales of discretionary items like supplies, that are difficult to isolate and quantify.
The table below presents a reconciliation of Mexico joint venture net income to Mexico joint venture EBITDA: Fiscal years ended January 28, 2023 January 29, 2022 January 30, 2021 (dollars in thousands) (52 weeks) (52 weeks) (52 weeks) Net income $ 24,757 $ 21,773 $ 14,225 Depreciation 19,820 15,679 12,249 Income tax expense 9,409 11,390 6,229 Foreign currency (gain) loss (268 ) (431 ) 704 Interest expense, net 5,449 5,263 4,740 EBITDA $ 59,167 $ 53,674 $ 38,147 50% of EBITDA $ 29,584 $ 26,837 $ 19,074 (2) Store pre-opening and closing expenses were adjusted for periods prior to fiscal 2023.
The table below presents a reconciliation of Mexico joint venture net income to Mexico joint venture EBITDA: Fiscal years ended February 3, 2024 January 28, 2023 January 29, 2022 (dollars in thousands) (53 weeks) (52 weeks) (52 weeks) Net income $ 32,375 $ 24,757 $ 21,773 Depreciation 26,141 19,820 15,679 Income tax expense 11,449 9,409 11,390 Foreign currency loss (gain) 1,520 (268 ) (431 ) Interest expense, net 4,966 5,449 5,263 EBITDA $ 76,451 $ 59,167 $ 53,674 50% of EBITDA $ 38,226 $ 29,584 $ 26,837 (2) Acquisition-related integration costs include direct costs resulting from acquiring and integrating businesses.
Seasonality Our financial performance is not significantly impacted by seasonality, as the majority of our sales are generated by pet parents caring for their pets year-round.
Segment We operate under one reportable segment and support and serve pets and their parents through our integrated ecosystem of pet care centers, services, and e-commerce. Seasonality Our financial performance is not significantly impacted by seasonality, as the majority of our sales are generated by pet parents caring for their pets year-round.
Net cash provided by operating activities was $346.0 million in fiscal 2022 compared with net cash provided by operating activities of $358.2 million in fiscal 2021. The decrease in operating cash flow was due to lower operating income, higher interest payments, higher cash paid for payroll and fringe as well as payouts of prior year accrued incentive bonuses.
The decrease in operating cash flow was due to lower operating income, higher interest payments, higher cash paid for payroll and fringe as well as payouts of prior year accrued incentive bonuses. This was partially offset by lower cash paid for advertising and lower cash payments on operating leases due to the timing of rent payments.
In fiscal 2023, we expect to spend approximately $225 million to $250 million in capital expenditures. 56 Capital expenditures by category during the periods set forth below are as follows: Fiscal years ended (dollars in thousands) January 28, 2023 January 29, 2022 January 30, 2021 New and existing pet care center locations $ 146,432 $ 140,721 $ 80,776 Digital and information technology 78,611 57,319 68,232 Supply chain and other 52,977 41,070 10,552 Total capital expenditures $ 278,020 $ 239,110 $ 159,560 Financing Activities Net cash used in financing activities was $33.8 million for fiscal 2022, compared with $18.8 million used in financing activities in fiscal 2021 and $146.6 million used in financing activities in fiscal 2020.
Capital expenditures by category during the periods set forth below are as follows: Fiscal years ended (dollars in thousands) February 3, 2024 January 28, 2023 January 29, 2022 New and existing pet care center locations $ 121,815 $ 146,432 $ 140,721 Digital and information technology 70,598 78,611 57,319 Supply chain and other 33,185 52,977 41,070 Total capital expenditures $ 225,598 $ 278,020 $ 239,110 Financing Activities Net cash used in financing activities was $85.4 million for fiscal 2023, compared with $33.8 million used in financing activities in fiscal 2022 and $18.8 million used in financing activities in fiscal 2021. 58 Financing cash flows in fiscal 2023 primarily consisted of $75.0 million in principal repayments on the term loan, borrowings and repayments under the ABL Revolving Credit Facility, and payments for tax withholdings on stock-based awards.
The Company paid an additional $18.9 million of term loan principal payments in fiscal 2020. For more information regarding these activities, refer to Note 7, “ Senior Secured Credit Facilities ,” and Note 8, “ Senior Notes ,” in the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K.
The increase was primarily driven by higher interest rates on the First Lien Term Loan. For more information refer to Note 7, “ Senior Secured Credit Facilities ,” in the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K.
As of January 28, 2023, our purchase obligations and commitments were $353.2 million of which $294.1 million is considered short-term.
As of February 3, 2024, our purchase obligations and commitments were $349.0 million of which $281.1 million is considered short-term.
As we saw the major purchase trend shift and growth into areas like 46 e-commerce, services, and veterinary care, we actively invested to build capabilities and offerings to effectively capitalize on the opportunity.
Customer Pet Purchase Trends Our multi-channel ecosystem is designed to support our customers regardless of how customers choose to shop for their pet care needs. As we saw the major purchase trend shift and grow into areas like e-commerce, services, and veterinary care, we actively invested to build capabilities and offerings to effectively capitalize on the opportunity.
Details of these changes and a reconciliation of the definitions prior to fiscal 2023 to the go-forward definition is presented in the tables and related footnotes below. 53 The table below reflects the calculation of Adjusted EBITDA and Adjusted EBITDA Margin for the periods presented: Fiscal years ended January 28, 2023 January 29, 2022 January 30, 2021 (dollars in thousands) (52 weeks) (52 weeks) (52 weeks) Net income (loss) attributable to Class A and B-1 common stockholders $ 90,801 $ 164,417 $ (26,483 ) Interest expense, net 100,611 77,335 218,430 Income tax expense (benefit) 35,347 53,473 (3,337 ) Depreciation and amortization 193,828 172,431 174,836 Income from equity method investees (12,976 ) (10,883 ) (6,482 ) Loss on extinguishment and modification of debt — 20,838 17,549 Asset impairments and write offs 1,992 10,918 15,606 Equity-based compensation 60,784 49,265 12,915 Other non-operating loss (income) 12,667 (34,497 ) — Mexico joint venture EBITDA (1) 29,584 26,837 19,074 Store pre-opening expenses (2) 14,993 14,765 9,228 Store closing expenses (2) 5,168 5,028 7,782 Non-cash occupancy-related costs (3) 8,432 8,114 19,240 Acquisition-related integration costs (4) 15,314 — — Other costs (5) 25,790 33,437 25,990 Adjusted EBITDA, as defined through fiscal 2022 $ 582,335 $ 591,478 $ 484,348 Store pre-opening expenses (2) (14,993 ) (14,765 ) (9,228 ) Store closing expenses (2) (5,168 ) (5,028 ) (7,782 ) Non-cash occupancy-related costs (3) (8,432 ) (8,114 ) (19,240 ) Other costs (5) (22,973 ) (15,202 ) (20,535 ) Adjusted EBITDA, as defined beginning fiscal 2023 $ 530,769 $ 548,369 $ 427,563 Net sales $ 6,035,967 $ 5,807,149 $ 4,920,202 Net margin (6) 1.5 % 2.8 % (0.5 )% Adjusted EBITDA Margin, as defined through fiscal 2022 (6) 9.6 % 10.2 % 9.8 % Adjusted EBITDA Margin, as defined beginning fiscal 2023 (6) 8.8 % 9.4 % 8.7 % (1) Mexico Joint Venture EBITDA represents 50 percent of the entity’s operating results for all periods, as adjusted to reflect the results on a basis comparable to Adjusted EBITDA.
In addition, other companies in our industry may define Adjusted EBITDA differently, limiting its usefulness as a comparative measure. 55 The table below reflects the calculation of Adjusted EBITDA and Adjusted EBITDA Margin for the periods presented: Fiscal years ended February 3, 2024 January 28, 2023 January 29, 2022 (dollars in thousands) (53 weeks) (52 weeks) (52 weeks) Net (loss) income attributable to Class A and B-1 common stockholders $ (1,280,210 ) $ 90,801 $ 164,417 Interest expense, net 147,504 100,611 77,335 Income tax (benefit) expense (27,613 ) 35,347 53,473 Depreciation and amortization 200,782 193,828 172,431 Income from equity method investees (16,188 ) (12,976 ) (10,883 ) Loss on extinguishment and modification of debt 920 — 20,838 Goodwill impairment 1,222,524 — — Asset impairments and write offs 2,833 1,992 10,918 Equity-based compensation expense 81,859 60,784 49,265 Other non-operating (income) loss (4,727 ) 12,667 (34,497 ) Mexico joint venture EBITDA (1) 38,226 29,584 26,837 Acquisition-related integration costs (2) — 15,314 — Other costs (3) 35,193 2,817 18,235 Adjusted EBITDA $ 401,103 $ 530,769 $ 548,369 Net sales $ 6,255,284 $ 6,035,967 $ 5,807,149 Net margin (4) (20.5 )% 1.5 % 2.8 % Adjusted EBITDA Margin 6.4 % 8.8 % 9.4 % (1) Mexico joint venture EBITDA represents 50% of the entity’s operating results for the periods presented, as adjusted to reflect the results on a basis comparable to our Adjusted EBITDA.
Our product offering leverages a broad, carefully curated assortment of owned brand and exclusive merchandise and partnerships with premium third-party brands to provide customers with high quality nutrition without artificial ingredients, complemented by a wide variety of premium pet care supplies and companion animals.
Our product offering leverages a broad assortment of national, owned brand and exclusive merchandise, providing customers with a wide variety of nutritional options, including health-focused options free from artificial ingredients, complemented by a wide variety of pet care supplies and companion animals.
Vital Care Premier memberships are at the top of our integrated loyalty programs, followed by Vital Care Core and our other perks programs that provide rewards for frequent purchasing.
Vital Care Premier memberships are at the top of our loyalty programs, followed by Vital Care Core and our perks programs that provide rewards for frequent purchasing. We strive to be a company that is improving millions of pet lives as well as the lives of pet parents and the partners who work for us.
Income from Equity Method Investees Investments for which the Company exercises significant influence but does not have control are accounted for under the equity method. Equity method investment activity is primarily related to a 50% joint venture with Grupo Gigante, S.A.B. de C.V. (the “Mexico joint venture”) to establish Petco locations in Mexico.
Equity method investment activity is primarily related to a 50% joint venture with Grupo Gigante, S.A.B. de C.V. (the “Mexico joint venture”) to establish Petco locations in Mexico. The Company’s share of the investee’s results is presented as either income or loss from equity method investees in the accompanying consolidated statements of operations.
(“Petco”, the “Company”, “we”, “our” and “us”) is a category-defining health and wellness company focused on improving the lives of pets, pet parents, and our own partners. We have consistently set new standards in pet care while delivering comprehensive pet wellness products, services and solutions, and creating communities that deepen the pet-pet parent bond.
(“Petco”, the “Company”, “we”, “our” and “us”) is a pet health and wellness company focused on improving the lives of pets, pet parents, and our own partners.
The decline period-over-period was primarily driven by higher SG&A costs of $41.0 million, higher interest expense of $24.2 million, a $47.2 million change in the remeasurement of our investment in Rover Group, Inc. offset partially by a 20.8 million loss on debt extinguishment recorded in fiscal 2021.
The decline period-over-period was primarily driven by a goodwill impairment charge of $1,222.5 million, higher SG&A costs of $110.1 million, higher interest expense of $49.3 million, offset partially by a $17.4 million change in the remeasurement of our investment in Rover Group, Inc.
Pet Industry Trends The U.S. pet care industry is large and growing, serving millions of households with pets, and represented a total addressable market of $133 billion in 2022. Since 2008, the industry has exhibited steady growth driven by an increase in the underlying pet population coupled with strong tailwinds associated with pet humanization.
Pet Industry Trends The U.S. pet care industry is large, serving millions of households with pets, and has exhibited steady growth driven by an increase in the pet population and trends in pet humanization and premiumization. Due to the essential, repeat nature of pet care, the industry has demonstrated resilience across economic cycles.
We are unable to quantify certain factors impacting sales described above due to the fact that such factors are based on input measures or qualitative information that do not lend themselves to quantification. Gross Profit Gross profit increased $0.5 million, or 0.0%, to $2.43 billion in fiscal 2022 compared to gross profit of $2.43 billion for fiscal 2021.
Service-related sales, which include veterinary hospitals, increased 15.3%, reflecting expansion and maturity of our veterinary hospital footprint and growth in our veterinary and grooming business. We are unable to quantify certain factors impacting sales described above due to the fact that such factors are based on input measures or qualitative information that do not lend themselves to quantification.
Our liquidity as of January 28, 2023 was $645.8 million inclusive of cash and cash equivalents of $201.9 million and $443.9 million of availability on the ABL Revolving Credit Facility.
Our liquidity as of February 3, 2024 was $572.0 million inclusive of cash and cash equivalents of $125.4 million and $446.6 million of availability on the ABL Revolving Credit Facility.
For more information regarding derivative instruments, refer to Note 9, “ Derivative Instruments ,” in the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K. Segment We operate under one reportable segment and support and serve pets and their parents through our integrated ecosystem of pet care centers, services, and e-commerce.
The interest rate collars become effective on December 31, 2024 and expire on December 31, 2026. For more information regarding derivative instruments, refer to Note 8, “ Derivative Instruments ,” in the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K.
As a percentage of sales, our gross profit rate was 40.2% for fiscal 2022 compared to 41.8% for fiscal 2021. The increase in gross profit was due to the overall increase in net sales.
Gross Profit Gross profit decreased $73.3 million, or 3.0%, to $2.35 billion in fiscal 2023 compared to gross profit of $2.43 billion for fiscal 2022. As a percentage of sales, our gross profit rate was 37.6% for fiscal 2023 compared to 40.2% for fiscal 2022.
The decrease in gross profit rate in fiscal 2022 as compared to fiscal 2021 was primarily driven by the mix impact of strength in consumables sales and lower supplies and companion animal sales combined with elevated supply chain costs.
The decrease in gross profit rate was primarily due to the mix impact of higher consumables sales and softer supplies and companion animal sales as well as investments made in bringing additional brands into our consumables assortment.
This was partially offset by lower cash paid for advertising and lower cash payments on operating leases due to the timing of rent payments. Net cash provided by operating activities was $358.2 million in fiscal 2021 compared with $268.6 million in fiscal 2020.
This was partially offset by an increase in sales, effective management of accounts payable, and lower payouts of prior year accrued incentive bonuses. Net cash provided by operating activities was $346.0 million in fiscal 2022 compared with $358.2 million in fiscal 2021.
While we offer pet parents a full spectrum of product choices within our high standards of nutrition and quality, our assortment is differentially weighted towards premium products to address the needs of the growing number of health-conscious pet parents.
While we offer pet parents a full spectrum of product choices, we maintain a number of premium products to address ongoing humanization and premiumization trends in the market. We integrate our product offering with our services business which includes veterinary care, grooming and training.
Talent and Culture We see our Petco partners as the core to building a purpose-driven performance culture.
If sales of such products are not significant, we do not increase the average basket size of customers purchasing such products, or we are unsuccessful in transitioning such customers into higher margin products over time, then our profitability could be adversely affected. Talent and Culture We see our Petco partners as the core to building a purpose-driven performance culture.